Angiostatin: a circulating endothelial cell inhibitor that suppresses angiogenesis and tumor growth. 1994

M S O'Reilly, and L Holmgren, and Y Shing, and C Chen, and R A Rosenthal, and Y Cao, and M Moses, and W S Lane, and E H Sage, and J Folkman
Children's Hospital, Boston, Massachusetts, USA.

UI MeSH Term Description Entries
D008175 Lung Neoplasms Tumors or cancer of the LUNG. Cancer of Lung,Lung Cancer,Pulmonary Cancer,Pulmonary Neoplasms,Cancer of the Lung,Neoplasms, Lung,Neoplasms, Pulmonary,Cancer, Lung,Cancer, Pulmonary,Cancers, Lung,Cancers, Pulmonary,Lung Cancers,Lung Neoplasm,Neoplasm, Lung,Neoplasm, Pulmonary,Pulmonary Cancers,Pulmonary Neoplasm
D008954 Models, Biological Theoretical representations that simulate the behavior or activity of biological processes or diseases. For disease models in living animals, DISEASE MODELS, ANIMAL is available. Biological models include the use of mathematical equations, computers, and other electronic equipment. Biological Model,Biological Models,Model, Biological,Models, Biologic,Biologic Model,Biologic Models,Model, Biologic
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009374 Neoplasms, Experimental Experimentally induced new abnormal growth of TISSUES in animals to provide models for studying human neoplasms. Experimental Neoplasms,Experimental Neoplasm,Neoplasm, Experimental
D009389 Neovascularization, Pathologic A pathologic process consisting of the proliferation of blood vessels in abnormal tissues or in abnormal positions. Angiogenesis, Pathologic,Angiogenesis, Pathological,Neovascularization, Pathological,Pathologic Angiogenesis,Pathologic Neovascularization,Pathological Angiogenesis,Pathological Neovascularization
D010446 Peptide Fragments Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques. Peptide Fragment,Fragment, Peptide,Fragments, Peptide
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D010958 Plasminogen Precursor of plasmin (FIBRINOLYSIN). It is a single-chain beta-globulin of molecular weight 80-90,000 found mostly in association with fibrinogen in plasma; plasminogen activators change it to fibrinolysin. It is used in wound debriding and has been investigated as a thrombolytic agent. Profibrinolysin,Glu-Plasminogen,Glutamic Acid 1-Plasminogen,Glutamyl Plasminogen,1-Plasminogen, Glutamic Acid,Glu Plasminogen,Glutamic Acid 1 Plasminogen,Plasminogen, Glutamyl
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D002642 Chick Embryo The developmental entity of a fertilized chicken egg (ZYGOTE). The developmental process begins about 24 h before the egg is laid at the BLASTODISC, a small whitish spot on the surface of the EGG YOLK. After 21 days of incubation, the embryo is fully developed before hatching. Embryo, Chick,Chick Embryos,Embryos, Chick

Related Publications

M S O'Reilly, and L Holmgren, and Y Shing, and C Chen, and R A Rosenthal, and Y Cao, and M Moses, and W S Lane, and E H Sage, and J Folkman
April 2005, Journal of pharmacological sciences,
M S O'Reilly, and L Holmgren, and Y Shing, and C Chen, and R A Rosenthal, and Y Cao, and M Moses, and W S Lane, and E H Sage, and J Folkman
January 1998, Angiogenesis,
M S O'Reilly, and L Holmgren, and Y Shing, and C Chen, and R A Rosenthal, and Y Cao, and M Moses, and W S Lane, and E H Sage, and J Folkman
January 1997, EXS,
M S O'Reilly, and L Holmgren, and Y Shing, and C Chen, and R A Rosenthal, and Y Cao, and M Moses, and W S Lane, and E H Sage, and J Folkman
March 1997, Deutsche medizinische Wochenschrift (1946),
M S O'Reilly, and L Holmgren, and Y Shing, and C Chen, and R A Rosenthal, and Y Cao, and M Moses, and W S Lane, and E H Sage, and J Folkman
December 2004, Molecular cancer therapeutics,
M S O'Reilly, and L Holmgren, and Y Shing, and C Chen, and R A Rosenthal, and Y Cao, and M Moses, and W S Lane, and E H Sage, and J Folkman
November 1999, Clinical cancer research : an official journal of the American Association for Cancer Research,
M S O'Reilly, and L Holmgren, and Y Shing, and C Chen, and R A Rosenthal, and Y Cao, and M Moses, and W S Lane, and E H Sage, and J Folkman
December 2004, International journal of cancer,
M S O'Reilly, and L Holmgren, and Y Shing, and C Chen, and R A Rosenthal, and Y Cao, and M Moses, and W S Lane, and E H Sage, and J Folkman
April 2001, Clinical cancer research : an official journal of the American Association for Cancer Research,
M S O'Reilly, and L Holmgren, and Y Shing, and C Chen, and R A Rosenthal, and Y Cao, and M Moses, and W S Lane, and E H Sage, and J Folkman
April 2024, Biochimica et biophysica acta. Molecular basis of disease,
M S O'Reilly, and L Holmgren, and Y Shing, and C Chen, and R A Rosenthal, and Y Cao, and M Moses, and W S Lane, and E H Sage, and J Folkman
June 2002, Urology,
Copied contents to your clipboard!